Biogen Completes Acquisition of Alcyone Therapeutics
Provided By GlobeNewswire
Last update: Nov 14, 2025
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx™ drug delivery system.
Read more at globenewswire.com174.1
+1.6 (+0.93%)
Find more stocks in the Stock Screener
BIIB Latest News and Analysis
